Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue

Journal of Medical Virology

Volumn 61, Issue 2, 2000, Pages 241-250

  Liu, Mei Ying ^a,b   Shih, Ya Yi ^a   Li, Long Yuan ^a   Chou, Sheng Ping ^c   Sheen, Tzung Shiahn ^a   Chen, Chi Long ^a   Yang, Czau Siung ^a   Chen, Jen Yang ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Bcl; BHRF1 expression; Epstein Barr virus; Nasopharyngeal carcinoma

Indexed keywords

ANTIBODY; GENE PRODUCT; PROTEIN BCL 2;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS;

AMINO ACIDS; ANTIBODIES, VIRAL; APOPTOSIS REGULATORY PROTEINS; BIOPSY; BLOTTING, SOUTHERN; CARCINOMA; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; CYTOPLASM; DNA-BINDING PROTEINS; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NASOPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TRANS-ACTIVATORS; VARIATION (GENETICS); VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0034014020     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200006)61:2<241::AID-JMV11>3.0.CO;2-2     Document Type: Article

References (51)

1. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Linsten T, Turka LA, Mao X, Nunez G, Thompson CB. 1993. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
2. Brooks L, Yao QY, Rickinson AB, Young LS. 1992. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: co-expression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66: 2689-2697.
3. Busson P, McCoy R, Sadler R, Gilligan K, Tursz T, Raab-Traub N. 1992. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 66:3257-3262.
4. Chen F, Hu LF, Ernberg I, Klein G, Winberg G. 1995. Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. J Gen Virol 76:131-138.
5. Chen JY, Liu MY, Chen CJ, Hsu MM, Tu SM, Lee HH, Kou SL, Yang CS. 1985. Antibody to Epstein-Barr virus specific DNase as a marker for the early detection of nasopharyngeal carcinoma. J Med Virol 17:47-49.
6. Chen JY, Chen CJ, Liu MY, Lynn TC, Shieh T, Tu SM, Beasley RP, Hwang LY, Lee HH, Kou SL, Yang CS. 1989. Antibody to EpsteinBarr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. J Med Virol 27:269-273.
7. Chiang AKS, Tao Q, Srivastava G, Ho FCS. 1996. Nasal NK-and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 68:285-290.
8. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC. 1995. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733-736.
9. Cleary ML, Smith SD, Sklar J. 1986. Cloning and structural analysis of cDNA for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28.
10. Cochet C, Martel-Renoir D, Grunewald V, Bosq J, Cochet G, Schwaab G, Bernaudin JF, Joab I. 1993. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 197:358-365.
11. Cohen JI, Wang F, Mannick J, Kieff E. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 86:9558-9562.
12. Dawson CW, Eliopoulos AG, Dawson J, Young LS. 1995. BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene 9:69-77.
13. Dawson CW, Dawson J, Jones R, Ward K, Young L. 1998. Functional differences between BHRF1, the Epstein-Barr virus-encoded bcl-2 homologue, and bcl-2 in human epithelial cells. J Virol 72:9016-9024.
14. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B. 1988. Expression of Epstein-Barr virus encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42:329-338.
15. Henle W, Henle G, Ho HC, Burtin P, Cachin Y, Clifford P, de Schryver A, de The G, Diehl V, Klein G. 1970. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and control groups. J Natl Cancer Inst 44:225-231.
16. Henle G, Henle W. 1976. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17:1-7.
17. Hinuma Y, Grace J. 1967. Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures. Proc Soc Exp Biol Med 124:107-111.
18. Horner D, Lewis M, Farrell PJ. 1995. Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers. Intervirology 38: 195-205.
19. Howe JG, Shu MD. 1989. Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements. Cell 57:825-834.
20. Hsu SM, Raine L. 1984. The use of avidin-biotin-peroxidase complex (ABC) in diagnostic and research pathology. In: DeLellis RA, editor. Advances in immunochemistry. New York: Mason Publishing Inc. p 31-42.
21. Huang H, Zhou JH, Zhou SM, Hu JH, Pan XH, Kong XT, Yu L, Sun XY, Wu W. 1997. Epstein-Barr virus BHRF1 prohibits the cells of nasopharyngeal carcinoma from apoptosis. J Laryngol Otol 111: 1147-1150.
22. Kawanishi M. 1997. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. J Virol 71:3319-3322.
23. Kaye KM, Izumi KM, Kieff E. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90:9150-9154.
24. Khanim F, Dawson C, Meseda CA, Dawson J, Mackett M, Young LS. 1997. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates. J Gen Virol 78:2987-2999.
25. Liu MY, Chang YL, Ma J, Yang HL, Hsu MM, Chen CJ, Chen JY, Yang CS. 1997. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma. J Med Virol 52:262-269.
26. Liu MY, Shin YY, Chou SP, Chen CJ, Sheen TS, Yang CS, Chen JY. 1998. Antibody against the Epstein-Barr virus BHRF-1 protein, a homologue of Bcl-2, in patients with nasopharyngeal carcinoma. J Med Virol 56:179-185.
27. Lu QL, Elia G, Lucas S, Thomas JA. 1993. Bcl-2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 53:29-35.
28. Martel-Renoir D, Gruneward V, Touitou R, Schwaab G, Joab I. 1995. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol 76:1401-1408.
29. Menezes J, Leibold W, Klein G, Clements G. 1975. Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt lymphoma. Biomedicine 22:276-284.
30. Miller G, Shope T, Lisco H, Stitt D, Lipman M. 1972. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Nat Acad Sci USA 69:383-387.
31. Niedobitek G, Young LS, Sam CK, Brooks L, Prasad U, Rickinson AB. 1992. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcioma. Am J Pathol 140:879-887.
32. Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
33. Qu L, Rowe DT. 1992. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol 66:3715-3724.
34. Oudejans JJ, Jiwa M, van der Brule AJ, Grasser FA, Horstman A, Vos W, Kluin PM, van der Val P, Walboomers JM, Meijer CJ. 1995. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Am J Pathol 147:923-933.
35. Pearson GR, Luka J, Petti L, Sample J, Birkenbach M, Braun D, Kieff, E. 1987. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151-161.
36. Pulvertaft R. 1965. A study of malignant tumours in Nigeria by short-term tissue culture. J Clin Pathol 18:261-273.
37. Sam CK, Brooks LA, Niedobitek G, Young LS, Prasad U, Rickinson AB. 1993. Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int J Cancer 53:957-962.
38. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chain terminating inhibitor. Proc Nat Acad Sci USA. 74:5463-5467.
39. Sbih-Lammali F, Berger F, Busson P, Ooka T. 1996. Expression of the DNase encoded by the BGLF5 gene of Epstein-Barr virus in nasopharyngeal carcinoma epithelial cells. Virology 222:64-74.
40. Southern EM. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517.
41. Swanson PE. 1994. Microwave antigen retrieval in citrate buffer. Lab Med 25:520-522.
42. Takada K, Horinouchi K, Ono Y, Aya T, Osato T, Takahashi M, Hayasaka S. 1991. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147-156.
43. Takeuchi H, Kobayashi R, Hasegawa M, Hirai M. 1996. Detection of latent infection by Epstein-Barr virus in peripheral blood cells of healthy individuals and in non-neoplastic tonsillar tissue from patients by reverse transcription-polymerase chain reaction. J Virol Meth 58:81-89.
44. Theodorakis P, D'Sa-Eipper C, Subramanian T, Chinnadurai G. 1996. Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene 12:1707-1713.
45. Tierney RJ, Steven N, Yang LS, Rickinson AB. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374-7385.
46. Tomkinson B, Robertson E, Kieff E, 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67:2014-2025.
47. Vaux D, Cory S, Adams J. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442.
48. Wolf H, zur Hausen H, Becker V. 1973. Epstein-Barr virus genomes in epithelial nasopharyngeal carcinoma cells. Nature 244:245-247.
49. Wu TC, Mann RB, Epstein JI, MacMahon E, Lee WA, Charache P, Hayward SD, Kurman RJ, Hayward GS, Ambinder RF. 1991. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. Am J Pathol 138:1461-1469.
50. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A. 1988. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051-1065.
51. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L. 1970. EB-virus DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature 237:189-190.